Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novartis
Age
20–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Japanese patients with mild to moderate essential hypertension aged 20 to 80 years
Blood pressure: Mean (based on 3 recordings at 1-2 minute intervals) sitting diastolic blood pressure values on 14 days or 3 days before the treatment should meet the following criteria:
* 14 days before treatment: ≥ 90 mmHg and \< 110 mmHg
* 3 days before treatment: ≥ 95 mmHg and \< 110 mmHg
* The difference in mean sitting diastolic blood pressure between 14 days and 3 days before the treatment is within 10 mmHg
Body weight no less than 50 kg
You may not be if
Patients with mean (based on 3 recordings at 1-2 minute intervals) systolic blood pressure ≥ 180 mmHg and/or mean diastolic blood pressure ≥ 110 mmHg at Day -28, Day -14 and Day -3.
Patients with or suspected of having secondary hypertension
Patients suspected of having malignant hypertension
Clareo Health | Pharmacokinetic and Pharmacodynamic Profiles of Aliskiren in Japanese Patients With Mild to Moderate Essential Hypertension
